Furthermore, it has been widely recognized that IL-6 could be useful for monitoring the effectiveness of anti-TB drugs and, together with sCD14, used to distinguish the active state of the disease (Yong et al., 2019; Boni et al., 2022). The gene discussed is IL6; the disease is tuberculosis.